Proteinuria Treatment Market Forecast and Segments, 2016-2026

pradnya.86

American Diabetic Association stated that people with high blood pressure and diabetes are at high risk for developing proteinuria. Thus, increase in diabetic and hypertensive patients worldwide are the main driving factors for the growth of proteinuria treatment market.

Proteinuria

Treatment

Market

Share, Global Trends,

Analysis, Research, Report,

Opportunities,

Segmentation and Forecast,

20162026

Future Market Insights

www.futuremarketinsights.com

sales@futuremarketinsights.com


Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting

services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,

technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.

We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.

Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and

Retail.

We have a global presence with delivery centers across India specializing in providing global research reports and country

research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We

combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our

client.

Research

Sector Coverage

Capabilities

• Customized Research

• Syndicated Research

• Investment Research

• Social Media Research

• Automotive and Transportation

• Chemicals & Materials

• Electronics, Semiconductor, and ICT • Food and Beverages

• Retail and Consumer Products

• Services and Utilities

• Industrial Automation and Equipment • Energy, Mining, Oil, and

• Healthcare, Pharmaceuticals & Medical Devices Gas

Customized

Research

Syndicated

Research

Investment

Research

Social Media

Research

Subscription Information

For detailed subscription information please contact

Hari. T (Sr. Manager - Global Business Development)

T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268

Email: hari.t@futuremarketinsights.com


Report Description

Proteinuria is also called as albuminuria is a condition in which urine contains abnormal

(excessive) amount of protein. It is a disease which results from damage within the kidneys. The

kidney performs filtration of waste, minerals and fluids from the blood to the urine. When

kidneys do not perform filtration properly that results an abnormal (excessive) amount of

proteins (albumin and globulin) excrete through the urine. Sign and symptom of proteinuria

includes edema present in face, arms, hands, abdomen and hypertension with foamy urine. Risk

factors for proteinuria includes, diabetes and hypertension (high blood pressure) mostly and

sometimes obesity and age over 65.

American Diabetic Association stated that people with high blood pressure and diabetes are at

high risk for developing proteinuria. Thus, increase in diabetic and hypertensive patients

worldwide are the main driving factors for the growth of proteinuria treatment market. Kidney

disease often has no early symptoms. Hence, lack of awareness among people about proteinuria

is expected to restrain the growth of global proteinuria treatment market.

Proteinuria Treatment Market: Drivers and Restraints

Types of proteinuria includes Transient and Orthostatic proteinuria. Proteinuria can be caused by

diseases not involving the kidneys, such as multiple myeloma, a cancer of the plasma cells in the

bone marrow.


Report Description

In diabetes, the main causes of proteinuria are high blood glucose levels over a period of years.

Pre-eclampsia, a condition which can affect pregnant women, includes very high blood pressure

and is another potential cause of protein in the urine.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-

1486

Proteinuria Treatment Market: Segmentation

Proteinuria treatment market can be segmented on the basis of drug type, distribution channel

and geography.

Based on drug type, proteinuria treatment market can be segmented as follows:

• ACE inhibitors (angiotensin-converting enzyme inhibitors)

• ARBs (angiotensin receptor blockers)

• DPP (dipeptidyl peptidase) IV inhibitors

Based on distribution channel, proteinuria treatment market can be segmented as

follows:

• Hospitals including hospital pharmacies

• Clinics

• Retail Pharmacies


Report Description

Proteinuria Treatment Market: Overview

Proteinuria can be diagnosed by urine albumin to creatinine ratio (UACR) test, glomerular

filtration rate (GFR) test, renal ultrasound scan, and kidney biopsy test. Since proteinuria is a

symptom and not a disease itself, medical care focuses on treating the underlying condition,

such as normalizing blood pressure in people with hypertension or controlling blood sugar levels

in those with diabetes. However, drugs are even prescribed for people with diabetes and high

blood pressure.

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1486

Proteinuria Treatment Market: Region-wise Outlook

Region wise, the global proteinuria treatment marketis classified into regions namely, North

America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and

Africa. North America dominates the global market for proteinuria treatment due to high

prevalence rate of diabetes and hypertension among North American population. Moreover,

technological advancements in diagnostic test further accentuates the market growth in this

region. Europe holds the second position in proteinuria treatment owing to its large geriatric

population base (people above 65 years of age).


Report Description

Asia-pacific holds the third and fourth position in the global proteinuria treatment market due

to lack of sufficient healthcare facilities (diagnostic test).

Proteinuria Treatment Market: Key Players

Some of the key players contributing to the global proteinuria treatment market includes Eli Lilly

And Company, Bristol-Myers Squibb, Merck & Co, Inc., AstraZeneca Plc., Reddys Lab, and

Novartis AG.


Thank You!

To know more about us, please visit our website:

www.futuremarketinsights.com

For sales queries or new topics email us on:

sales@futuremarketinsights.com

For other queries contact:

Future Market Insights: 616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989, United States

T: +1-347-918-3531 | D: +1-845-579-5705

More magazines by this user
Similar magazines